AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Novel Modulators of Melanocortin Receptors for the Treatment of Depression and Anxiety

Detailed Technology Description

Title: Novel Modulators of Melanocortin Receptors for the Treatment of Depression and Anxiety Invention: The invention is the use of the melanocortin 5 receptor (MC5R) ligand to treat depressive and anxiety disorders. MC5R antagonism is the proposed mechanism of action. Background: Depression and anxiety often have similar treatment, but experiencing the full effects of current pharmacotherapy can range from weeks to months. Antidepressants and anxiolytics are associated with a number of side effects including an increased risk of suicidal thoughts in those taking antidepressants. Therefore, a novel pathway is needed for rapid onset with minimal side effects. Applications:Pharmaceutical companies Advantages:Provides a treatment for depressive and anxiety disorders Licensing Manager:Paul EynottPaulE@tla.arizona.edu(520) 471-3612

Country/Region

USA

For more information, please click Here